Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam for Anxiety in Palliative Care
NCT06330584Phase 2Recruiting
- Sponsor
- Insel Gruppe
- Start
- Dec 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midazolam in anxiety disorder, sponsored by Insel Gruppe. Started Dec 2024; status: recruiting.
02
Drugs
midazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT06330584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06330584.